Zhejiang Xina Pharmaceutical Co., Ltd.
PrivateLast Round
Series C
Mar 3, 2026
Est. Valuation
$555.09M
Total Funding Raised
$215.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Zhejiang Xina Pharmaceutical Co., Ltd. is a biotechnology company that develops innovative systemic inhalation drug delivery platforms and formulations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhejiang Xina Pharmaceutical Co., Ltd. Comparables
Compare Zhejiang Xina Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou Inhal Pharma Co., Ltd. | 80% | |
| Chance Pharmaceuticals | 79% | |
| Pulmatrix, Inc. | 78% |
Zhejiang Xina Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 3, 2026 | ||||
| Series B | Jul 5, 2022 | ||||
| Series A | Mar 18, 2021 |
Zhejiang Xina Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPC | Series A |
| 盛世投资 (Shengshi Investment) | Series B |
| Lilly Asia Ventures | Series A |
| State Development and Investment Group Co., Ltd. | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
$94M round led by Citic Medical Fund and Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund.
- Jul 5, 2022
$60M round raised with participation from State Development and Investment Group Co., Ltd.
Zhejiang Xina Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zhejiang Xina Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Zhejiang Xina Pharmaceutical Co., Ltd. a public or private company?
Zhejiang Xina Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Zhejiang Xina Pharmaceutical Co., Ltd.?
Zhejiang Xina Pharmaceutical Co., Ltd. is a private company with no public stock price. Caplight tracks Zhejiang Xina Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Zhejiang Xina Pharmaceutical Co., Ltd. worth (valuation)?
Zhejiang Xina Pharmaceutical Co., Ltd.'s valuation is estimated at $555.1M based on funding round data.
Can I buy Zhejiang Xina Pharmaceutical Co., Ltd. stock?
Zhejiang Xina Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Zhejiang Xina Pharmaceutical Co., Ltd.'s last funding round?
Zhejiang Xina Pharmaceutical Co., Ltd.'s most recent funding round was Series C on March 3, 2026.
Who are the main investors in Zhejiang Xina Pharmaceutical Co., Ltd.?
Key investors in Zhejiang Xina Pharmaceutical Co., Ltd. include MPC, Lilly Asia Ventures.
Will Zhejiang Xina Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Zhejiang Xina Pharmaceutical Co., Ltd..
How can I track Zhejiang Xina Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zhejiang Xina Pharmaceutical Co., Ltd.'s secondary market activity and sign up for updates.